Literature DB >> 30027157

The New Classes of Synthetic Illicit Drugs Can Significantly Harm the Brain: A Neuro Imaging Perspective with Full Review of MRI Findings.

S Creagh1, D Warden2, M A Latif3, A Paydar4.   

Abstract

Synthetic drugs contain substances that are pharmacologically similar to those found in traditional illicit drugs. Some of the most commonly abused synthetic drugs include synthetic marijuana, bath salts, ecstasy, N-bomb, methamphetamine and anabolic steroids. Many of them share the same chemical properties and physiologic responses with the drugs they mimic and may exaggerate the pathologic response in the brain leading to addiction. These drugs have detrimental (and often irreversible) effects on the brain and primarily affect the central nervous system by two mechanisms: 1) Neural hyper stimulation via increasing activation of certain neurotransmitters (norepinephrine, dopamine, and serotonin), 2) Cause significant reduction in CNS neural connectivity affecting various brain regions such as the basal ganglia, hippocampus, cerebellum, parietal lobe, and globus pallidus. Furthermore these drugs sometimes have severe, life-threatening adverse effects on the human body. A few structural MRI studies have been conducted in synthetic drug abusers to reveal the effects of these drugs on the brain parenchyma. This review article will describe the potential brain imaging findings in synthetic drug abusers as demonstrated by several case reports and the primary literature.

Entities:  

Keywords:  Cannabinoids; Cathinone; MRI; N-methylamphetamine; Pathophysiologic; Pharmacologically

Year:  2018        PMID: 30027157      PMCID: PMC6048967     

Source DB:  PubMed          Journal:  Clin Radiol Imaging J


  17 in total

1.  Severe cerebellitis following methadone poisoning.

Authors:  Fionnghuala Mills; Suzanna C MacLennan; Catherine J Devile; Dawn E Saunders
Journal:  Pediatr Radiol       Date:  2007-10-20

2.  Long-term effects of marijuana use on the brain.

Authors:  Francesca M Filbey; Sina Aslan; Vince D Calhoun; Jeffrey S Spence; Eswar Damaraju; Arvind Caprihan; Judith Segall
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-10       Impact factor: 11.205

3.  Severe leukoencephalopathy following acute oxycodone intoxication.

Authors:  Yazmin Morales Odia; Madhavi Jinka; Wendy C Ziai
Journal:  Neurocrit Care       Date:  2010-08       Impact factor: 3.210

4.  The Psychoactive Designer Drug and Bath Salt Constituent MDPV Causes Widespread Disruption of Brain Functional Connectivity.

Authors:  Luis M Colon-Perez; Kelvin Tran; Khalil Thompson; Michael C Pace; Kenneth Blum; Bruce A Goldberger; Mark S Gold; Adriaan W Bruijnzeel; Barry Setlow; Marcelo Febo
Journal:  Neuropsychopharmacology       Date:  2016-03-21       Impact factor: 7.853

5.  Effects of ecstasy (MDMA) on the brain in abstinent users: initial observations with diffusion and perfusion MR imaging.

Authors:  L Reneman; C B Majoie; J B Habraken; G J den Heeten
Journal:  Radiology       Date:  2001-09       Impact factor: 11.105

6.  Brain and cognition abnormalities in long-term anabolic-androgenic steroid users.

Authors:  Marc J Kaufman; Amy C Janes; James I Hudson; Brian P Brennan; Gen Kanayama; Andrew R Kerrigan; J Eric Jensen; Harrison G Pope
Journal:  Drug Alcohol Depend       Date:  2015-05-07       Impact factor: 4.492

7.  The secret "spice": an undetectable toxic cause of seizure.

Authors:  Adam de Havenon; Brian Chin; Karen C Thomas; Pegah Afra
Journal:  Neurohospitalist       Date:  2011-10

8.  A delayed methadone encephalopathy: clinical and neuroradiological findings.

Authors:  Anna Zanin; Susanna Masiero; Maria Savina Severino; Milena Calderone; Liviana Da Dalt; Anna Maria Laverda
Journal:  J Child Neurol       Date:  2009-10-06       Impact factor: 1.987

9.  Neural correlates of the LSD experience revealed by multimodal neuroimaging.

Authors:  Robin L Carhart-Harris; Suresh Muthukumaraswamy; Leor Roseman; Mendel Kaelen; Wouter Droog; Kevin Murphy; Enzo Tagliazucchi; Eduardo E Schenberg; Timothy Nest; Csaba Orban; Robert Leech; Luke T Williams; Tim M Williams; Mark Bolstridge; Ben Sessa; John McGonigle; Martin I Sereno; David Nichols; Peter J Hellyer; Peter Hobden; John Evans; Krish D Singh; Richard G Wise; H Valerie Curran; Amanda Feilding; David J Nutt
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-11       Impact factor: 12.779

10.  MRI brain findings in ephedrone encephalopathy associated with manganese abuse: Single-center perspective.

Authors:  Renata Poniatowska; Małgorzata Lusawa; Agnieszka Skierczyńska; Grzegorz Makowicz; Bogusław Habrat; Halina Sienkiewicz-Jarosz
Journal:  Pol J Radiol       Date:  2014-06-18
View more
  3 in total

1.  In vivo toxicometabolomics reveals multi-organ and urine metabolic changes in mice upon acute exposure to human-relevant doses of 3,4-methylenedioxypyrovalerone (MDPV).

Authors:  Ana Margarida Araújo; Márcia Carvalho; Vera Marisa Costa; José Alberto Duarte; Ricardo Jorge Dinis-Oliveira; Maria de Lourdes Bastos; Paula Guedes de Pinho; Félix Carvalho
Journal:  Arch Toxicol       Date:  2020-11-19       Impact factor: 5.153

Review 2.  New psychoactive substances: a review and updates.

Authors:  Abu Shafi; Alex J Berry; Harry Sumnall; David M Wood; Derek K Tracy
Journal:  Ther Adv Psychopharmacol       Date:  2020-12-17

3.  In Silico Studies of Phytoconstituents from Piper longum and Ocimum sanctum as ACE2 and TMRSS2 Inhibitors: Strategies to Combat COVID-19.

Authors:  Divya Jindal; Vibha Rani
Journal:  Appl Biochem Biotechnol       Date:  2022-02-14       Impact factor: 2.926

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.